Jitka Poljaková

740 citations
24 papers · 626 indexed · h-index 14
Topics
Cancer therapeutics and mechanisms (19 papers)Neuroblastoma Research and Treatments (12 papers)Lung Cancer Research Studies (9 papers)
Partner nations
CzechiaGermanyBelgium

In The Last Decade

Jitka Poljaková

24 papers receiving 618 citations

Peers

Jitka Poljaková
Comparison fields: 5 of 70
  • Molecular Biology 476
  • Oncology 227
  • Pharmacology 136
  • Neurology 100
  • Organic Chemistry 83
Replace L H Patterson with:
L H Patterson United Kingdom
Xin Ku China
Jeffrey O. Saunders United States
Gregory R. Ott United States
Madeline E. Kavanagh United Kingdom
Samer Haidar Germany
Andrea Loaiza‐Perez Argentina
Sherry L. Ralston United States
S. CROS France
Karimullah A. Zirvi United States
Jitka Poljaková relative to L H Patterson United Kingdom L H Patterson's profile →
Citations per field
00.5×5.3×
L H Patterson · 1×
Citations per year

Countries citing papers authored by Jitka Poljaková

Since Specialization
Citations

This map shows the geographic impact of Jitka Poljaková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitka Poljaková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitka Poljaková more than expected).

Fields of papers citing papers by Jitka Poljaková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitka Poljaková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitka Poljaková. The network helps show where Jitka Poljaková may publish in the future.

Co-authorship network of co-authors of Jitka Poljaková

This figure shows the co-authorship network connecting the top 25 collaborators of Jitka Poljaková. A scholar is included among the top collaborators of Jitka Poljaková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitka Poljaková. Jitka Poljaková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 17
3 8
4 58
5 7
6
Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
9
7 11
8 65
9 23
10
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
18
11 6
12 57
13 20
14
Isolation and partial characterization of catechol 1,2-dioxygenase of phenol degrading yeast Candida tropicalis.
3
15 9
16 20
17 36
18 52
19 15
20 11

About Jitka Poljaková

Jitka Poljaková is a scholar working on Neurology, Oncology and Molecular Biology, having authored 24 papers that have together received 626 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (19 papers), Neuroblastoma Research and Treatments (12 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Pharmacology (136 citations), Toxicology (33 citations) and Oncology (227 citations). Jitka Poljaková has collaborated with scholars based in Czechia, Germany and Belgium. Frequent co-authors include Marie Stiborová, Eva Frei, Tomáš Eckschlager, Jan Hraběta, René Kizek, Lucie Bořek-Dohalská, Dagmar Aimová, Jiřı́ Hudeček, Kristina Forsterová and Martin Dračínský. Their work appears in journals such as Cancer Research, International Journal of Cancer and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026